Riskpilot← Back to searchSign inGet full accessHOLTAN KLINIKKEN AS
ASActiveOrg 994272993Folkestadvegen 12, 3802 Bø I TelemarkDental practice care activities · NACE 8623Est. 20095 employees
Revenue 2024
NOK 8,9M
+19% vs 2023
EBITDA margin
5.3%
+25% vs 2023
Equity ratio
36.1%
Financial strength
Net profit 2024
NOK 346K
+47% vs 2023
| Revenue | NOK 8,9M | +19% |
| EBITDA | NOK 470K | +25% |
| Net profit | NOK 346K | +47% |
| Total assets | NOK 2,9M | -17% |
| Equity | NOK 1M | +50% |
| Employees | 5 | — |
Legal name
HOLTAN KLINIKKEN AS
Org number
994272993
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
13. juli 2009
Share capital
NOK 212 304
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Salg av administrative tjenester, tannhelsetjenester og tannprodukter, utleie og drift av fast eiendom, samt annen virksomhet som står i naturlig tilknytning til dette.
Address
Folkestadvegen 12, 3802 Bø I Telemark
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 306 | 5 983 | 6 563 | 7 501 | 8 926 |
| Staff expenses | −1 484 | −1 913 | −2 237 | −2 198 | −2 516 |
| EBITDA | 98 | 187 | 106 | 376 | 470 |
| Depreciation & amort. | −84 | −77 | −83 | −161 | −154 |
| EBIT | 14 | 110 | 22 | 216 | 316 |
| Net financials | 21 | 20 | 29 | 87 | 128 |
| Profit before tax | 35 | 130 | 52 | 303 | 444 |
| Tax | −43 | 28 | 11 | 67 | 98 |
| Net profit | 78 | 101 | 40 | 236 | 346 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 064 | 2 078 | 1 697 | 3 481 | 2 876 |
| Equity | 315 | 416 | 456 | 692 | 1 038 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 749 | 1 663 | 1 241 | 2 789 | 1 838 |
| Total debt | 749 | 1 663 | 1 241 | 2 789 | 1 838 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
36.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
33.3%
This company
18.4%
Market median
+81% vs market
20202024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20202024
Asset turnover
3.10×
This company
1.12×
Market median
+177% vs market
20202024
Debt / equity
1.77×
This company
0.62×
Market median
-185% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HOLTAN KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Holtan Saga | Chief Executive Officer | 0 companies |
| Inge Holtan Saga | Chairman | 0 companies |
| Tone Heidi Holtan Saga | Board of Directors | 0 companies |
| Lene Nygård Holtan | Board of Directors | 0 companies |